Dexcom Inc risk profile
25 Normal where most of the sector sits
Measured 1 September 2026 from DXCM's filed statements. Recomputed nightly.
25 (Normal), driven by Competitive position at 36, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 28 | Normal | Stable | One-year price volatility — 41.4% |
| Operating pressure | 24 | Normal | Easing | Operating-margin drift — +6.1 percentage points |
| Cash conversion | 6 | Contained | Stable | Capital spending against operating cash — 0.25x |
| Leverage and coverage | 10 | Contained | Easing | Current ratio — 1.88x |
| Competitive position | 36 | Normal | Stable | Operating-margin gap against peers — +6.1 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.